SCHEMBL6598164

SCHEMBL6598164

O=C(O)Cc1ccc(NC(=O)NCc2cccn2-c2cc3cc(C(=O)O)c(=O)[nH]c3cc2C(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 12/20 0.49
GRIA2 P42262 12/20 0.49
GRIA3 P42263 12/20 0.49
GRIA4 P48058 12/20 0.49
GRIK1 P39086 9/20 0.45
GRIK2 Q13002 9/20 0.45
GRIK3 Q13003 9/20 0.45
GRIK4 Q16099 9/20 0.45
GRIK5 Q16478 9/20 0.45
RORC P51449 3/20 0.38
MAPT P10636 3/20 0.37
LMNA P02545 1/20 0.37
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
GAA P10253 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6597918 0.91 GRIA1 (0.57) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL6596766 0.88 RORC (0.40) GRIA1GRIA2GRIA3GRIA4RORC
SCHEMBL6595172 0.87 GRIA1 (0.48) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL6596186 0.79 GRIA1 (0.43) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL6596000 0.78 GRIA1 (0.56) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL6598030 0.77 GRIA1 (0.81) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL6598151 0.75 FPR2 (0.39) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL6598565 0.72 GRIA1 (0.65) GRIA1GRIA2GRIA3GRIA4
SCHEMBL6595165 0.69 NR1H2 (0.33) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL6593784 0.67 GRIA1 (0.83) GRIA1GRIA2GRIA3GRIA4GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1156044-B1 6-SUBSTITUTED HETEROQUINOLINECARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-08-25 EP disclosed
US-6562839-B1 Effective for the therapy of disorder of cerebral nerve cells as antagonists against excitatory amino acid receptors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-05-13 US disclosed
EP-1156044-A1 6-SUBSTITUTED HETEROQUINOLINECARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2001-11-21 EP disclosed